Abstract
Patients with acute, uncomplicated urinary tract infections were treated with either amoxicillin-clavulanic acid (A-C) in fixed combination or cefaclor for 10 days in a prospective randomized comparison. The A-C group included 29 women and 1 man (mean age, 25.5 years), and the cefaclor group included 35 women and 1 man (mean age, 24.9 years). The cure rates were 26 (87%) of 30 with A-C and 26 (72%) of 36 with cefaclor (P greater than 0.20). There was one failure in each group, each caused by an isolate resistant to ampicillin. There were one relapse and two reinfections in the A-C group, compared with seven relapses and two reinfections in the cefaclor group. Side effects, including patients started on antibiotics but whose cultures did not confirm urinary tract infections, were diarrhea in 7 (16%) and rash in 1 (2%) of 44 A-C patients, compared with diarrhea in 1 (2%) and yeast vaginitis in 3 (6%) of 48 cefaclor patients. Although the A-C group had a greater proportion of antibody-coated bacterium-positive infections (22 versus 18 with cefaclor), there was a lower recurrence rate with fewer relapses in patients treated with A-C.
MeSH Terms
Adult
Amoxicillin/administration & dosage,adverse effects
Ampicillin/pharmacology
Cefaclor/adverse effects,therapeutic use
Cephalexin/analogs & derivatives
Clavulanic Acid
Clavulanic Acids/administration & dosage,adverse effects
Clinical Trials as Topic
Drug Combinations
Female
Humans
Male
Penicillin Resistance
Prospective Studies
Urinary Tract Infections/drug therapy,microbiology
Chemicals
Clavulanic Acids
Drug Combinations
Clavulanic Acid
Cefaclor
Ampicillin
Amoxicillin
Cephalexin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Gurwith M J
Stein G E
Gurwith D
References (15)
15 references, click to expand
-
Antibody-coated bacteria in the urine and the site of urinary-tract infection.
N Engl J Med. 1974 Mar 14;290(11):588-90
PMID: 4591064
-
Amoxicillin therapy of acute urinary infections in adults.
Antimicrob Agents Chemother. 1977 May;11(5):780-4
PMID: 327919
-
Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.
J Clin Microbiol. 1979 Feb;9(2):205-7
PMID: 34624
-
Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.
Urology. 1979 Sep;14(3):233-6
PMID: 384643
-
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
J Antimicrob Chemother. 1979 Nov;5(6):705-9
PMID: 395156
-
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
Lancet. 1980 Mar 22;1(8169):620-3
PMID: 6102627
-
Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique.
JAMA. 1980 Aug 8;244(6):561-64
PMID: 6993706
-
Causes of the acute urethral syndrome in women.
N Engl J Med. 1980 Aug 21;303(8):409-15
PMID: 6993946
-
Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
J Antimicrob Chemother. 1981 Mar;7(3):229-36
PMID: 6974165
-
Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure.
Am J Med. 1981 Nov;71(5):841-5
PMID: 7304657
-
Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.
Antimicrob Agents Chemother. 1981 Dec;20(6):800-2
PMID: 7034642
-
Diagnosis of coliform infection in acutely dysuric women.
N Engl J Med. 1982 Aug 19;307(8):463-8
PMID: 7099208
-
Effect of food on the bioavailability and tolerance of clavulanic acid/amoxycillin combination.
J Antimicrob Chemother. 1982 Aug;10(2):131-9
PMID: 7118763
-
Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.
Antimicrob Agents Chemother. 1982 Oct;22(4):672-7
PMID: 7181477
-
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.
Antimicrob Agents Chemother. 1982 Aug;22(2):346-9
PMID: 6765418